Literature DB >> 2413359

Constitutive synthesis of interleukin-3 by leukaemia cell line WEHI-3B is due to retroviral insertion near the gene.

S Ymer, W Q Tucker, C J Sanderson, A J Hapel, H D Campbell, I G Young.   

Abstract

Interleukin-3 (multi-CSF) is a multilineage haematopoietic growth regulator that initiates the proliferation and differentiation of multipotential stem cells. Complementary DNA clones encoding interleukin-3 (IL-3) have recently been isolated and the structure of the IL-3 gene determined. IL-3 is produced by T lymphocytes or T lymphomas only after stimulation with antigens, mitogens or chemical activators such as phorbol esters. The myelomonocytic leukaemia line WEHI-3B also produces IL-3 but its production is constitutive and the WEHI-3B cells do not appear to produce significant levels of any of the other lymphokines normally secreted by T lymphocytes after stimulation. It has been proposed that the genetic change leading to the constitutive expression of IL-3 may have been a key event in the development of this leukaemia. We report here that the constitutive synthesis of IL-3 by the WEHI-3B cell line is due to the insertion of an endogenous retrovirus-like element close to the 5' end of the gene. The insertion, an intracisternal A particle (IAP) genome, is positioned with its 5' long terminal repeat (LTR) close to the promoter region of the IL-3 gene, resulting in constitutive synthesis of IL-3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413359     DOI: 10.1038/317255a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  76 in total

1.  C/EBP epsilon mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut).

Authors:  A Khanna-Gupta; T Zibello; H Sun; J Lekstrom-Himes; N Berliner
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Interaction of H-2Eb with an IAP retrotransposon in the A20/2J B cell lymphoma.

Authors:  C E Malstrom; A L Kotsenas; B Jones
Journal:  Immunogenetics       Date:  1992       Impact factor: 2.846

3.  Identification of regulatory elements within the minimal promoter region of the human endogenous ERV9 proviruses: accurate transcription initiation is controlled by an Inr-like element.

Authors:  G La Mantia; B Majello; A Di Cristofano; M Strazzullo; G Minchiotti; L Lania
Journal:  Nucleic Acids Res       Date:  1992-08-25       Impact factor: 16.971

4.  A novel, plasmid-based system for studying gene rearrangements in mammalian cells.

Authors:  R S Krauss; I B Weinstein
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

5.  Identification and characterization of novel human endogenous retroviral sequences prefentially expressed in undifferentiated embryonal carcinoma cells.

Authors:  G La Mantia; D Maglione; G Pengue; A Di Cristofano; A Simeone; L Lanfrancone; L Lania
Journal:  Nucleic Acids Res       Date:  1991-04-11       Impact factor: 16.971

6.  Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

Authors:  C Lavau; S J Szilvassy; R Slany; M L Cleary
Journal:  EMBO J       Date:  1997-07-16       Impact factor: 11.598

Review 7.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

8.  Integration of the BALB/c ecotropic provirus into the colony-stimulating factor-1 growth factor locus in a myc retrovirus-induced murine monocyte tumor.

Authors:  W R Baumbach; E M Colston; M D Cole
Journal:  J Virol       Date:  1988-09       Impact factor: 5.103

9.  Characterization of amplified intracisternal A-particle elements encoding integrase.

Authors:  K K Lueders; Z Grossman; J W Fewell
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

10.  v-myb blocks granulocyte colony-stimulating factor-induced myeloid cell differentiation but not proliferation.

Authors:  G Patel; B Kreider; G Rovera; E P Reddy
Journal:  Mol Cell Biol       Date:  1993-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.